Banmédica Companies
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Banmédica Companies - overview
Established
1988
Location
Santiago, -, Chile
Primary Industry
Healthcare
About
Based in Chile, Banmédica Companies provides essential healthcare services through health insurance and management, catering primarily to the local population. Based in Santiago, Chile, founded in 1988, Banmédica Companies is a Chilean healthcare holding specializing in private clinics, health insurance, and integrated medical services, with major operations across Chile and Latin America and Colombia. In November 2025, Patria Investments and Linzor Capital Partners agreed to acquire Banmédica Companies from UnitedHealth Group for USD 1 billion. Empresas Banmedica primarily operates within the healthcare sector in Chile, offering a comprehensive suite of health services through its subsidiaries, Isapre Banmédica and Isapre Vida Tres.
The core product offerings include health insurance services that cater to over 750,000 Chileans, providing medical coverage, preventive care, and comprehensive health management. The company emphasizes its commitment to improving healthcare access by significantly increasing the availability of critical care beds, achieving a reported increase of 288%. Its services are designed to meet the needs of individual customers, families, and corporate clients seeking reliable health insurance solutions. Additionally, Empresas Banmedica invests in state-of-the-art hospital infrastructure and employs highly qualified medical professionals to ensure high-quality care.
These services are primarily targeted at the Chilean market, although the company has also expanded its offerings to international health insurance solutions, broadening its reach to clients outside of Chile. Empresas Banmedica generates revenue primarily through its health insurance services, which are structured around subscription-based models for individual and group coverage. Clients pay regular premiums for access to various health benefits, including consultations, medical procedures, and hospitalization. The financial transactions typically occur through direct billing to clients who utilize the services, ensuring that care is accessible and timely.
The company's revenue structure is reinforced by partnerships with healthcare providers, allowing them to offer extensive network options to their insured members. This direct-to-consumer approach is complemented by business-to-business arrangements, as Empresas Banmedica also collaborates with corporations to provide tailored health insurance solutions for their employees. The pricing plans are strategically designed to accommodate a range of customer needs, although specific pricing details are not disclosed. Through these models, Empresas Banmedica sustains its operations and continues to invest in healthcare advancements.
The November 2025 acquisition will support the company's growth and expansion plans.
Primary Industry
Healthcare
Sub Industries
Healthcare
Website
www.empresasbanmedica.cl
Verticals
HealthTech
Total Amount Raised
Subscriber access only
Banmédica Companies - financials
| Fiscal Year Ended | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 1,059,581,733,000 | 1,328,307,498,000 | 1,420,202,448,000 | 1,531,181,447,000 | 1,626,777,022,000 | - | 1,835,108,526,000 | - | - | - |
| % Revenue Growth (YoY) | - | 25.4% | 6.9% | 7.8% | 6.2% | - | - | - | - | - |
| EBITDA (USD) | 102,041,677,000 | 86,698,230,000 | 135,992,300,000 | 153,814,629,000 | 94,272,524,000 | - | 137,616,595,000 | - | - | - |
| Operating Income (USD) | 77,683,706,000 | 86,698,230,000 | 105,229,528,000 | 118,987,461,000 | 94,272,524,000 | - | 137,616,595,000 | - | - | - |
| Operating Margin | 7.3% | 6.5% | 7.4% | 7.8% | 5.8% | - | 7.5% | - | - | - |
| % EBITDA Margin | 9.6% | 6.5% | 9.6% | 10.0% | 5.8% | - | 7.5% | - | - | - |
| NET Income (USD) | 48,108,429,000 | 53,413,946,000 | 66,040,313,000 | 72,985,046,000 | 57,470,276,000 | - | 71,419,459,000 | - | - | - |
| % Net Margin | 4.5% | 4.0% | 4.7% | 4.8% | 3.5% | - | 3.9% | - | - | - |
Banmédica Companies - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Corporate Carve Out | Announced | Banmédica Companies | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.